# Spondylitis Trial of Apremilast for Better Rheumatic Therapy

> **NCT00944658** · PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 38 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** Apremilast
- **DRUG:** Placebo (sugar pill)

## Key facts

- **NCT ID:** NCT00944658
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944658, "Spondylitis Trial of Apremilast for Better Rheumatic Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00944658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*